The incoming WTO DG warns that vaccine nationalism could frustrate pandemic recovery.
Pfizer Inc. and BioNTech's vaccine may offer some protection against the new variants of coronavirus.
Pfizer Inc has announced that a final analysis of clinical-trial data of its experimental Covid-19 vaccine showed it was 95% effective.
Pfizer Inc. and BioNTech's COVID-19 vaccine has shown incredible results in more than 90% of infections in a study of thousands of volunteers.
The US said it is likely to have enough safe and effective COVID-19 vaccines to inoculate Americans by the end of 2020.
The drugmakers hope to get to the initial target figure of 30,000 participants for the vaccine trial.
The vaccine may be approved for use by humans within 3 to 7 days of registration by regulators.